Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus

The human microbiome plays a very important role in the normal functioning of both metabolic and immune systems. Changes in gut microbiota (dysbiosis) possibly contribute to the development of metabolic and autoimmune diseases. There is close association between the human gut microbiome and Vitamin...

Full description

Saved in:
Bibliographic Details
Main Authors: Milena Velizarova, Vesselina Yanachkova, Tzenka Boneva, Silva Giragosyan, Ivelina Mihaleva, Pavlina Andreeva-Gateva, Dobrin Svinarov, Ivanka Dimova
Format: Article
Language:English
Published: Taylor & Francis Group 2023-03-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13102818.2023.2209662
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846157473128382464
author Milena Velizarova
Vesselina Yanachkova
Tzenka Boneva
Silva Giragosyan
Ivelina Mihaleva
Pavlina Andreeva-Gateva
Dobrin Svinarov
Ivanka Dimova
author_facet Milena Velizarova
Vesselina Yanachkova
Tzenka Boneva
Silva Giragosyan
Ivelina Mihaleva
Pavlina Andreeva-Gateva
Dobrin Svinarov
Ivanka Dimova
author_sort Milena Velizarova
collection DOAJ
description The human microbiome plays a very important role in the normal functioning of both metabolic and immune systems. Changes in gut microbiota (dysbiosis) possibly contribute to the development of metabolic and autoimmune diseases. There is close association between the human gut microbiome and Vitamin D metabolism. The objective of our study was to characterize the composition of the gut microbiome in patients with type 2 diabetes mellitus (T2DM) in comparison to controls with normal glucose tolerance, and to correlate the Vitamin D status with the changes in the gut microbiome. Totally, 15 patients with T2DM and 16 controls were enrolled in the study. The complex gut microbiome was analysed by next generation sequencing (NGS) in both groups, additionally divided into subgroups according to serum 25-hydroxyVitamin D (25[OH]D) levels. We found a significant decrease in butyrate-producing bacteria Eubacterium spp. and an increase in lipopolysaccharide (LPS) - positive bacteria Enterobacter spp., Escherichia spp. and Pseudomonas spp. in T2DM patients compared to controls. Control individuals with 25[OH]D levels of over 80 nmol/L were characterized with significantly decreased amount of Escherichia spp. and Pseudomonas spp. and increased Eubacterium spp. On the other hand, 25[OH]D < 80nmol/L levels in diabetic patients were related with lower content of butyrate-producing bacteria and higher levels of LPS-positive bacteria. The results showed an influence of gut microbiome on the glucose homeostasis and a relationship between Vitamin D levels and the gut microbiome.
format Article
id doaj-art-c413981b58604126a18fdcb88f45c4c2
institution Kabale University
issn 1310-2818
1314-3530
language English
publishDate 2023-03-01
publisher Taylor & Francis Group
record_format Article
series Biotechnology & Biotechnological Equipment
spelling doaj-art-c413981b58604126a18fdcb88f45c4c22024-11-25T09:24:34ZengTaylor & Francis GroupBiotechnology & Biotechnological Equipment1310-28181314-35302023-03-0137110.1080/13102818.2023.2209662Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitusMilena Velizarova0Vesselina Yanachkova1Tzenka Boneva2Silva Giragosyan3Ivelina Mihaleva4Pavlina Andreeva-Gateva5Dobrin Svinarov6Ivanka Dimova7Department of Clinical Laboratory, Medical University of Sofia; University Hospital “Alexandrovska”, Sofia, BulgariaObstetrics and Gynecology, "Dr. Sterev" Hospital, Sofia, BulgariaUniversity Hospital “Alexandrovska”, Medical University of Sofia, Sofia, BulgariaMolecular Medicine Centre, Medical University of Sofia, Sofia, BulgariaDepartment of Pharmacology and Toxicology, Faculty of Medicine, Medical University of Sofia, Sofia, BulgariaDepartment of Pharmacology and Toxicology, Faculty of Medicine, Medical University of Sofia, Sofia, BulgariaDepartment of Clinical Laboratory, Medical University of Sofia; University Hospital “Alexandrovska”, Sofia, BulgariaDepartment of Medical Genetics, Faculty of Medicine, Medical University of Sofia, Sofia, BulgariaThe human microbiome plays a very important role in the normal functioning of both metabolic and immune systems. Changes in gut microbiota (dysbiosis) possibly contribute to the development of metabolic and autoimmune diseases. There is close association between the human gut microbiome and Vitamin D metabolism. The objective of our study was to characterize the composition of the gut microbiome in patients with type 2 diabetes mellitus (T2DM) in comparison to controls with normal glucose tolerance, and to correlate the Vitamin D status with the changes in the gut microbiome. Totally, 15 patients with T2DM and 16 controls were enrolled in the study. The complex gut microbiome was analysed by next generation sequencing (NGS) in both groups, additionally divided into subgroups according to serum 25-hydroxyVitamin D (25[OH]D) levels. We found a significant decrease in butyrate-producing bacteria Eubacterium spp. and an increase in lipopolysaccharide (LPS) - positive bacteria Enterobacter spp., Escherichia spp. and Pseudomonas spp. in T2DM patients compared to controls. Control individuals with 25[OH]D levels of over 80 nmol/L were characterized with significantly decreased amount of Escherichia spp. and Pseudomonas spp. and increased Eubacterium spp. On the other hand, 25[OH]D < 80nmol/L levels in diabetic patients were related with lower content of butyrate-producing bacteria and higher levels of LPS-positive bacteria. The results showed an influence of gut microbiome on the glucose homeostasis and a relationship between Vitamin D levels and the gut microbiome.https://www.tandfonline.com/doi/10.1080/13102818.2023.2209662Type 2 diabetes mellitusgut microbiomeVitamin D25[OH]D
spellingShingle Milena Velizarova
Vesselina Yanachkova
Tzenka Boneva
Silva Giragosyan
Ivelina Mihaleva
Pavlina Andreeva-Gateva
Dobrin Svinarov
Ivanka Dimova
Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus
Biotechnology & Biotechnological Equipment
Type 2 diabetes mellitus
gut microbiome
Vitamin D
25[OH]D
title Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus
title_full Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus
title_fullStr Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus
title_full_unstemmed Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus
title_short Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus
title_sort relationship between vitamin d status and microbiome changes in bulgarian patients with type 2 diabetes mellitus
topic Type 2 diabetes mellitus
gut microbiome
Vitamin D
25[OH]D
url https://www.tandfonline.com/doi/10.1080/13102818.2023.2209662
work_keys_str_mv AT milenavelizarova relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus
AT vesselinayanachkova relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus
AT tzenkaboneva relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus
AT silvagiragosyan relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus
AT ivelinamihaleva relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus
AT pavlinaandreevagateva relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus
AT dobrinsvinarov relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus
AT ivankadimova relationshipbetweenvitamindstatusandmicrobiomechangesinbulgarianpatientswithtype2diabetesmellitus